Medtronic (MDT) Invested Capital (2014 - 2026)

Medtronic has disclosed Invested Capital across 13 years of filings, most recently posting $79.0 billion for Q3 2026.

• In Q3 2026, Invested Capital rose 2.95% year-over-year to $79.0 billion; the TTM figure through Jul 2026 stood at $79.0 billion (up 2.95% YoY), while the FY2026 annual figure was $78.0 billion, up 1.64% from the prior year.
• Invested Capital came in at $79.0 billion for Q3 2026 at Medtronic, up from $78.0 billion in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $79.7 billion in Q1 2023 to a low of $75.4 billion in Q2 2024.
• Average Invested Capital over 5 years is $77.2 billion, with a median of $76.8 billion recorded in 2022.
• Year-over-year, Invested Capital fell 4.16% in 2022 and increased 2.95% in 2026.
• Over 5 years, Invested Capital stood at $78.7 billion in 2022, then slipped by 2.47% to $76.7 billion in 2023, then increased by 0.41% to $77.0 billion in 2024, then increased by 1.19% to $78.0 billion in 2025, then climbed by 1.34% to $79.0 billion in 2026.
• Per Business Quant data, the three most recent Invested Capital figures were $79.0 billion in Q3 2026, $78.0 billion in Q2 2026, and $77.3 billion in Q1 2026.